Proteostasis Therapeutics (NASDAQ:PTI) Insider Buying and Selling Activity
Insider Ownership Percentage: 19.80%
Proteostasis Therapeutics (NASDAQ PTI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/4/2019 | Meenu Chhabra | Insider | Sell | 16,478 | $2.99 | $49,269.22 | 97,093 | |
| 1/28/2019 | Po Shun Lee | Insider | Sell | 1,600 | $3.00 | $4,800.00 | | |
| 10/26/2018 | Franklin M Berger | Director | Buy | 40,000 | $6.75 | $270,000.00 | 266,162 | |
| 12/18/2017 | Enterprise Associates 12 New | Major Shareholder | Buy | 2,000,000 | $5.00 | $10,000,000.00 | | |
| 12/18/2017 | Franklin M Berger | Director | Buy | 60,000 | $5.00 | $300,000.00 | 266,162 | |
| 12/18/2017 | Meenu Chhabra | Insider | Buy | 40,000 | $5.00 | $200,000.00 | 50,218 | |
| 12/14/2017 | Cormorant Asset Management, Ll | Major Shareholder | Sell | 504,027 | $4.88 | $2,459,651.76 | | |
| 3/13/2017 | Fmr Llc | Insider | Sell | 25,000 | $12.94 | $323,500.00 | | |
| 3/10/2017 | Fmr Llc | Insider | Sell | 25,000 | $12.04 | $301,000.00 | | |
| 3/9/2017 | Fmr Llc | Insider | Sell | 29,300 | $12.08 | $353,944.00 | | |
| 3/7/2017 | Fmr Llc | Insider | Sell | 60,000 | $13.01 | $780,600.00 | | |
| 3/3/2017 | Fmr Llc | Insider | Sell | 45,000 | $13.91 | $625,950.00 | | |
| 3/1/2017 | Fmr Llc | Insider | Sell | 45,000 | $14.62 | $657,900.00 | | |
| 2/27/2017 | Fmr Llc | Insider | Sell | 28,000 | $14.60 | $408,800.00 | | |
| 12/16/2016 | Franklin M Berger | Director | Buy | 40,000 | $11.17 | $446,800.00 | 192,162 | |
| 12/13/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 121,301 | $10.82 | $1,312,476.82 | | |
| 12/8/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 44,417 | $10.83 | $481,036.11 | | |
| 12/6/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 87,973 | $10.62 | $934,273.26 | | |
| 12/1/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 170,391 | $10.24 | $1,744,803.84 | | |
| 11/23/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 361,863 | $11.40 | $4,125,238.20 | | |
| 11/14/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 259,500 | $11.05 | $2,867,475.00 | | |
| 11/7/2016 | Cormorant Asset Management, Ll | Major Shareholder | Buy | 327,977 | $8.45 | $2,771,405.65 | | |
| 9/14/2016 | Enterprise Associates 12 New | Major Shareholder | Buy | 461,538 | $13.00 | $5,999,994.00 | | |
| 9/14/2016 | Franklin M Berger | Director | Buy | 69,230 | $13.00 | $899,990.00 | 166,162 | |
| 2/17/2016 | Bioventures Ltd Novartis | Major Shareholder | Buy | 375,000 | $8.00 | $3,000,000.00 | | |
| 2/17/2016 | Franklin M. Berger | Director | Buy | 25,000 | $8.00 | $200,000.00 | 96,932 | |
(Data available from 1/1/2013 forward)
